Monthly Archives: February 2013

21 02-2013
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences

VALENCIA, Calif., Feb. 21, 2013 /PRNewswire/ — SANGUINE BIOSCIENCES, INC. (“Sanguine”), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures. Sanguine engages research subjects...

Read more...